Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Wrong route of administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong route of administration in a 61-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. On 28-AUG-2025, the patient received Shingrix (unknown arm). On 28-AUG-2025, an unknown time after receiving Shingrix, the patient experienced wrong route of administration (Verbatim: Wrong route of administration). The outcome of the wrong route of administration was not applicable. Additional Information: GSK Receipt Date: 28-AUG-2025 The patient was given Shingrix via wrong route of administration. A nurse administered the vaccine via subsequent injection in the forearm.